1. M. Åsberg, B. Cronholm, F. Sjöqvist and D. Tuck, Relationship between plasma level of nortriptyline and therapeutic effect, Br. Med. J. 3: 331 – 334 (1971).
2. W.Z. Potter, L. Bertilsson and F. Sjöqvist, Clinical pharmacokinetics of psychotropic drugs–Fundamentals and practical aspects, in: “Handbook of Biological Psychiatry,” H.M. van Praag, M.H. Lader, O.J. Rafaelsen and E.J. Sachar, eds., Marcel Dekker Inc., New York (1980).
3. W. Hammer, C.M. Idestrom and F. Sjöqvist, Chemical control of antidepressant drug therapy, in: “Proceedings of the First International Symposium on Antidepressant Drugs,” S. Garattini and M.N.G. Dukes, eds., Excerpta Med. Congr. Ser., Vol. 122, Milan (1967), pp. 301–310.
4. W. Hammer and F. Sjöqvist, Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine- like compounds, Life Sci. 6: 1895 – 1903 (1967).
5. O. Borgå L. Palmér, A. Linnarsson and B. Holmstedt, Quantitative determination of nortriptyline and desmethylnortriptyline in human plasma by combined gas chromatography-mass spectrometry, Anal. Letters 4: 837 – 849 (1971).